News

MultiCell Technologies has been granted US patent: 7566567 by the US Patent and Trademark Office, covering its Fa2N-4 and Ea1C-35 immortalized human hepatocyte cell lines. Reportedly, Fa2N-4 and

Wake Pharma (Wake) has received American Podiatric Medical Association (APMA) seal of approval for its product – Wound-Be-Gone, based on a new oxygen free radical binding technology. Wound-Be-Gone

Anika Therapeutics (Anika) has received approval from Health Canada for Monovisc, its single injection viscosupplement, for the treatment of osteoarthritis of the knee. Anika expects to launch Monovisc

NextPharma has engaged the services of Ron Collins, to represent its business development affairs in the Eastern part of the US and Canada. The move is in response

The FDA has issued warning letters to eight companies marketing unlawful over-the-counter (OTC) topical drug products, containing the pain reliever – ibuprofen. According to the FDA, the products,

SOCMA has recommended its members to look at the progression of the Consumer Product Safety Improvement Act of 2008 (CPSIA), as the Kid-Safe Chemicals Act next month is

The Maryland Department of Health has selected Upp Technology to help improve the efficiency of their emergency operations. Upp, a provider of public health solutions, will provide a

XSpray Microparticles has launched its new GMP production facility in Malmo, Sweden. With the introduction of this new plant, XSpray is expected to provide quality drug particles and

Nutra Pharma has launched an over-the-counter (OTC) pain reliever, Cobroxin, for the treatment of stage 2 (moderate-to-severe) chronic pain. Cobroxin is claimed to be the first OTC pain